39 year old female was implanted on (b)(6) 2023.They were seen at their 2 week wound healing check on (b)(6) 2023.The patient presented with an incision site that was hard to touch, pink and itchy.The physician assistant determined the site to not be infected.On (b)(6) 2023, the patient called the after hours hotline reported that the site was hot, swollen and red.The provider prescribed a 7-day antibiotic regimen (keflex).The patient was directed to contact their implanted physician.On (b)(6) 2023, the patient was seen by the physician assistant again and was instructed to finish the antibiotics.On (b)(6) 2023, the patient called to report continued signs of an infection.They were prescribed a second round of antibiotics (doxycycline) but had to stop treatment due to an allergic reaction.On (b)(6) 2023, the patient was seen by a company representative.The company representative was informed by medical staff that the patient may have an infected incision.Patient was put a third round of antibiotics (keflex).On (b)(6) 2023, the patient was seen by implanting physician who confirmed that the infection was cleared.Patient was activated on (b)(6) 2023.There were no related issues noted.Company medical advisors reviewed the photos provided by the implanting physician.They concluded it is likely the patient had a dermabond reaction which evolved into cellulitis of the incision area.The incision appears to be closed.
|